Healthtech & Wellness VC Funds

InnovaHealth Partners is a private equity firm based in New York City, specializing in growth buyouts of established medical technology companies. Founded in 2016, the firm focuses on the highest growth sectors within the medical device industry, aiming to partner with exceptional management teams to build innovative, differentiated, and high-growth medical technology companies. InnovaHealth Partners manages approximately $290 million of committed capital, which is deployed across the U.S., Europe, and Israel. The firm’s investment strategy is centered on identifying and investing in companies that have the potential to address large unmet medical needs through advanced medical technologies. The team at InnovaHealth brings together over 100 years of combined experience in the medical device sector, having worked together for more than 15 years. The firm’s portfolio includes companies that are leaders in their respective fields, such as Materna Medical, Monteris Medical, and OrthoSpace. These companies are recognized for developing breakthrough technologies in areas like neurosurgery, women’s health, and orthopedic surgery. InnovaHealth Partners takes a hands-on approach to its investments, working closely with portfolio companies to drive growth, enhance operational efficiency, and ultimately improve patient outcomes. This commitment to collaboration and innovation has positioned InnovaHealth as a leading player in the medical device private equity landscape.

EnBW New Ventures (ENV) is the venture capital arm of EnBW, dedicated to investing in early and growth-stage startups that drive the energy transition and sustainability initiatives. Based in Karlsruhe, Germany, ENV has a strong focus on innovative technologies that support decarbonization and digital transformation in energy and related sectors​. ENV's portfolio includes a diverse range of companies, such as Cozero, which offers a comprehensive carbon management software for enterprises; Easelink, known for its Matrix Charging® technology that automates electric vehicle charging; and Intigriti, a global cybersecurity platform connecting companies with ethical hackers​. They also invest in startups like enspired, which automates energy trading, and Holo-Light, which provides augmented reality solutions for industrial applications​. Since its inception, ENV has invested over €125 million across 25 startups, aiming to accelerate the shift to sustainable energy and technologies​ (ENGIE New Ventures)​. The firm’s investments span various geographies and sectors, emphasizing innovations in energy efficiency, renewable energy, energy storage, and smart city solutions. ENV's approach involves not only financial investment but also leveraging EnBW's extensive industry expertise and network to support the growth and scaling of their portfolio companies. This hands-on partnership model has made ENV a significant player in the venture capital space, particularly in the clean energy and sustainability sectors.

Innovation Capital is a €21.1 million venture capital fund based in Sofia, Bulgaria, focused on supporting early-stage startups. The fund primarily invests in pre-seed and seed stages, offering equity and quasi-equity funding to companies across a variety of sectors. Their investment approach is sector-agnostic, covering industries like AI, e-commerce, healthcare, education, fintech, and cybersecurity. Innovation Capital aims to foster high-potential startups that can introduce disruptive innovations and scalable solutions within the local and international markets. The firm has built a diverse portfolio, with more than 100 companies under its belt, including innovative projects like Ubitrack Sport (machine learning for sports analytics) and Kabinet (telemedicine for mental health). They actively seek projects with strong business models and potential for growth, providing investments that range from €25,000 to €1 million depending on the stage of the startup. Innovation Capital also plays a key role in the regional ecosystem by managing accelerator programs, such as XLRadar, which helps early-stage startups refine their business models and gain market traction. The fund receives support from European Structural and Investment Funds, aiming to stimulate competitiveness and economic growth within Bulgaria​.

Innovation Endeavors is an early-stage venture capital firm co-founded by Eric Schmidt, former CEO of Google, and Dror Berman. Headquartered in Silicon Valley, the firm invests in startups driving the "Super Evolution" — a non-linear innovation approach addressing significant global challenges. The firm's investment strategy targets early-stage, seed, and Series A opportunities, typically committing between $1 million and $15 million per initial investment. They focus on supporting technical founders tackling complex engineering and scientific problems to revolutionize large industries. Key areas of focus include intelligent software, computing infrastructure, climate solutions, the physical economy, and engineering health. Innovation Endeavors is deeply involved with its portfolio companies, often taking board seats and leading or co-leading investment rounds. Notable investments include companies like Planet, AlphaSense, Afresh, and Gatik. The firm leverages its extensive networks in technology, academia, and venture capital to provide unparalleled support and opportunities for its community of entrepreneurs. Their mission is to incubate small teams with big ideas, helping them find the right team and partners to achieve their vision.

Innovation Industries is a leading European venture capital firm focused on deep tech investments. With approximately €850 million in assets under management, they specialize in sectors such as industrial tech, med tech, and food & agri tech. The firm targets high-growth potential companies that offer sustainable solutions and have a significant societal impact. Innovation Industries supports companies throughout their growth journey, from early-stage funding to scaling up. They can invest up to €50 million per company over multiple funding rounds, ensuring robust financial backing and strategic guidance. Their portfolio includes cutting-edge companies like Nearfield Instruments, Axelera AI, and Pharrowtech. The team at Innovation Industries brings diverse expertise in fields like physics, engineering, and biotechnology, providing a strong foundation to identify and nurture groundbreaking technologies. Their commitment to sustainability and responsible investment is evident in their rigorous environmental, social, and governance (ESG) criteria. Overall, Innovation Industries is dedicated to driving technological advancements that address fundamental challenges, aiming to create long-term value for both their investors and society at large.

Innovation Works (IW) is a leading early-stage investor in southwestern Pennsylvania, primarily focused on technology startups. Founded as part of the Ben Franklin Technology Partners network, IW has significantly contributed to the region's economic growth by investing in over 700 companies, which have collectively raised $3.3 billion in follow-on funding and created over 20,000 jobs. Notable sectors in IW's portfolio include robotics, life sciences, software, and clean energy. Some of their prominent investments are in companies like Aurora Innovation and Stack AV, which are part of the thriving robotics and autonomous vehicle industries in Pittsburgh. IW's support extends beyond funding, providing mentorship and resources through their accelerators, AlphaLab and AlphaLab Gear. In 2023, despite a national downturn in venture capital, Pittsburgh's tech sector saw a substantial increase in investments, reaching $3.12 billion, driven by significant activity in automation and AI. This positions Pittsburgh as an emerging tech hub with a growing number of new investors and global technology companies setting up satellite offices in the region. For startups looking to connect with IW, demonstrating innovation and potential for significant impact in high-opportunity markets will align with IW’s investment philosophy.

InnovationQuarter is the economic development agency for the Province of Zuid-Holland, focusing on enhancing the region’s economic structure through innovation. The agency is committed to supporting startups and scale-ups, particularly in sectors like high-tech systems, life sciences, energy, and the circular economy. InnovationQuarter offers various investment funds. InnovationQuarter Capital provides up to €5 million for innovative startups and scale-ups with high technological risk, supporting companies with strong management teams and scalable business models. ENERGIIQ, a €35 million fund, is aimed at commercializing proven energy innovations to reduce CO2 emissions, offering up to €4.3 million in venture capital and emphasizing collaborations with reputable co-investors. UNIIQ, a €47 million seed fund, focuses on the proof-of-concept phase, providing up to €350,000 in risk capital for the technical and market validation of innovations. Additionally, InnovationQuarter plays a significant role in internationalization, assisting Dutch businesses in expanding abroad and supporting foreign companies in establishing a presence in Zuid-Holland. The agency collaborates with various stakeholders, including major corporations, SMEs, educational institutions, and government organizations, to foster a dynamic and innovative ecosystem.

Innovestor Group is a prominent Nordic venture capital firm headquartered in Helsinki, Finland. Founded in 2014, it is one of the most active early-stage investors in the region, managing over €250 million across multiple funds. Innovestor focuses on sectors like life sciences, industrial technology, and digital health, with a particular emphasis on sustainable and scalable innovations. The firm is known for being the "first VC check" for many startups, supporting them from pre-seed through to Series A, primarily across the Nordics and Baltics. The firm operates through a combination of direct investments and co-investment syndication, making it a versatile player in the venture capital ecosystem. Innovestor’s portfolio includes nearly 100 high-growth companies, reflecting a diversified approach across sectors such as biotech, clean energy, and industrial automation. Recent initiatives include a €30 million Industry 4.0 fund aimed at fostering industrial tech advancements, and a dedicated €90 million Life Science & Health fund to support breakthroughs in biotech and healthcare. Innovestor distinguishes itself by not only providing capital but also facilitating collaborations between startups and large corporations, as seen through its accelerator programs like the PALO Accelerator. This approach helps startups scale efficiently by tapping into strategic partnerships and industry expertise. With offices throughout the region, Innovestor continues to drive the growth of Nordic+ startups by enabling them to scale internationally.

Inovia Capital, founded in 2007 by Chris Arsenault and others, is a venture capital firm based in Montreal with a significant presence in the Canadian tech ecosystem. The firm manages over $2.5 billion in assets across multiple funds, including early-stage venture and growth funds. Inovia focuses on partnering with founders to build impactful and enduring global companies, offering support from seed to IPO and beyond​. Notable investments in their portfolio include Lightspeed Commerce, AppDirect, Sonder, and Hopper. Inovia has achieved several successful exits, such as the IPOs of Lightspeed and Sonder, and acquisitions like Luxury Retreats by Airbnb and Well.ca by McKesson​. The firm's strategy emphasizes a hands-on approach, leveraging its team of experienced investors and operators to provide strategic guidance, mentorship, and access to a global network

Inovo VC is a seed-stage venture capital firm based in Warsaw, Poland, with a focus on startups from Central and Eastern Europe (CEE). They typically invest between €0.5 million and €4 million in early-stage companies, with the potential for follow-on investments up to €10 million. Inovo's portfolio includes over 30 companies, with notable successes such as Booksy, Infermedica, and Packhelp, each surpassing €100 million in valuation. Inovo's investment strategy spans various industries, including healthcare, AI and machine learning, developer tools, and SaaS-enabled marketplaces. The firm aims to support startups that can achieve significant global market presence and reach $100 million in revenue within a few years. They have a strong track record of working alongside other prominent funds such as a16z, Google’s Gradient Ventures, and Insight Partners. The fund's leadership team, consisting of Tomasz Swieboda, Michał Rokosz, and Maciej Małysz, brings extensive experience and a proven ability to identify and nurture high-potential startups. Their recent third fund, closed at €105 million, continues to support ambitious founders in the CEE region, aiming to create at least ten new unicorns in the coming years. Inovo VC's backers include private investors like European family offices and Polish tech entrepreneurs, as well as institutional investors such as the European Investment Fund and IFC, a member of the World Bank Group.

InseadAlum Ventures (IAV) is the first global venture fund dedicated to INSEAD alumni, founded in January 2017 by Deepak Shahdadpuri (MBA '98D) and Will Klippgen (MBA '03D). The fund is registered in Singapore with an additional office in Paris, and was created after the founders observed that many INSEAD entrepreneurs struggled to raise initial funding for their startups. IAV raised SGD $1 million from 17 INSEAD alumni who also agreed to serve as mentors to selected portfolio companies. The fund invests SGD 50,000 to SGD 200,000 per startup at the pre-seed stage, with the primary requirement that at least one co-founder must be an INSEAD alumnus. IAV deploys capital globally across all sectors with no geographic restriction. Portfolio companies include Switchee, a UK-based smart thermostat IoT startup that raised a GBP 480,000 seed round and was IAV's first investment; Felcana, a pet health monitoring company funded to launch its Health Monitoring Kit; and Different Dog, a premium chilled dog food brand in the UK that received investment in February 2019. Notable limited partners and mentors include Jani Rautiainen, co-founder of PropertyGuru, Southeast Asia's largest property portal, and Aloke Bajpai, principal founder of iXiGO.com, India's largest online travel search platform. IAV provides portfolio companies with mentorship from its 17 alumni investor base alongside capital, leveraging the global INSEAD network across finance, technology, and entrepreneurship. The fund's most recent tracked investments date to 2019, reflecting limited recent public deployment activity.

Insight Partners, founded in 1995 and headquartered in New York City, is a global venture capital and private equity firm renowned for investing in high-growth technology, software, and internet companies. The firm has a vast portfolio of over 1,600 investments, including notable companies like Calm, monday.com, WalkMe, and Checkout.com​. The firm is particularly known for its significant investments across various sectors such as IT infrastructure, cybersecurity, fintech, e-commerce, and DevOps. In 2022, Insight Partners closed its largest fund to date, raising over $20 billion, which underscored its aggressive investment strategy and commitment to high-growth companies​​. Insight Partners employs a hands-on approach to supporting its portfolio companies, offering extensive resources through its Onsite team. This team comprises over 130 experts in areas like sales, marketing, product development, and talent acquisition, dedicated to helping companies scale efficiently. This support has been crucial in helping many of their portfolio companies achieve significant growth and successful exits​. Overall, Insight Partners' combination of substantial financial resources, strategic support, and industry expertise positions it as a leading player in the global venture capital landscape​.

Insignia Ventures Partners, founded in 2017 and based in Singapore, is an early-stage venture capital firm that focuses on technology startups in Southeast Asia. The firm has made significant strides in the region, investing in over 90 companies across various industries, including fintech, e-commerce, and digital health. Notable investments in Insignia Ventures' portfolio include Carro, a leading online platform for buying and selling cars in Southeast Asia; Ajaib, a fast-growing digital retail investment platform in Indonesia; and GoTo, a major player in the Indonesian tech ecosystem formed from the merger of Gojek and Tokopedia. Other key investments are Appier, a Taiwanese AI-driven marketing technology company, and Shipper, a logistics and supply chain platform​​. Insignia Ventures Partners is led by Yinglan Tan, a former Sequoia Capital partner, and the firm is known for its hands-on approach, providing extensive support and resources to its portfolio companies. They aim to partner with founders early in their journey and help them scale through various growth stages​.

Insitor Partners is a venture capital firm dedicated to impact investing, focusing on early-stage companies in emerging and frontier markets across Asia, including Cambodia, India, Myanmar, and Pakistan. Established in 2009 and headquartered in Singapore, Insitor Partners aims to provide life-changing solutions for low-income consumers, improving access to essential services and products. The firm manages multiple funds, including the Insitor Impact Asia Fund I and II, with investments typically ranging from €1.5 million to €3 million. Insitor invests in sectors such as healthcare, education, housing, water and sanitation, agriculture, and financial inclusion. Their portfolio includes companies that foster sustainable living, better health, and economic growth for underserved communities. Insitor's investment strategy emphasizes a disciplined approach, focusing on high-impact entrepreneurs and scalable business models that can transform industries. They provide not only financial support but also operational guidance and access to a broad network of resources. By fostering synergies and sharing best practices, Insitor ensures that their portfolio companies can achieve significant social impact while delivering responsible financial returns.

Inspired Capital is a New York-based venture capital firm that focuses on early-stage investments, specifically leading Pre-Seed, Seed, and Series A rounds with check sizes ranging from $1 million to $15 million. Founded by Alexa von Tobel and Penny Pritzker, the firm aims to back fearless founders who are solving some of the hardest challenges facing humanity across various sectors, including AI, fintech, healthcare, industrial, labor and education, and other frontier technologies. Inspired Capital's mission is to partner with transformative founders who have brilliant ideas and relentless determination. They believe venture capital, when properly deployed, can be a powerful economic engine, driving innovation and creating significant long-term value. The firm's investment philosophy is centered around embracing big risks and supporting founders who challenge the status quo and develop new products and solutions to fix structurally broken markets. The team at Inspired Capital comprises experienced operators and investors, including General Partners Mark Batsiyan and Lucy Deland, Principal Kamran Ali, and Senior Associate Claire Pan. They bring extensive experience in building, scaling, and selling companies, as well as deep expertise in various industries. Notable companies in Inspired Capital's portfolio include Habi, a data-driven real estate platform in Latin America; QA Wolf, which focuses on automated browser testing; and Good Inside, a parenting co-pilot platform. The firm is committed to supporting its portfolio companies with hands-on guidance and a robust network to help them become category-defining businesses.

Insta Ventures is a venture capital firm founded in 2019, focusing on early-stage investments in IT and technology sectors. Based in Limassol, Cyprus, the firm targets startups in the seed to pre-Series A stages, typically investing between $100,000 and $500,000. Insta Ventures is known for its swift decision-making process, often concluding investment deals within one to two months after the first meeting. The firm’s investment strategy is centered around fast-growing, disruptive tech companies, particularly those in SaaS, B2B/B2B2C, AI, AR/VR, and FinTech. Insta Ventures places a strong emphasis on companies with a global market scope and those generating $0.1 to $1 million in annual recurring revenue. While the firm invests globally, it has a special focus on startups from the Nordics and Baltics. Insta Ventures also values co-investments and partners with other venture funds and accelerators to support its portfolio companies. The firm's portfolio includes companies like Ex-human, an AI platform for immersive conversations, and Warren.io, a cloud management platform.

Intel Capital, based in Santa Clara, California, is a leading venture capital firm and the investment arm of Intel Corporation. With a robust portfolio featuring 24 unicorns like Figure and AI21 Labs, Intel Capital has cemented its position in the tech industry. Their investments span across AI, cloud, cybersecurity, and semiconductor sectors, targeting companies that are pushing the boundaries of innovation. Notable investments include SecurityScorecard, DataRobot, and Syntiant. Intel Capital's global reach is significant, with investments in over 1,500 companies across 57 countries. They are stage-agnostic, typically investing from seed to growth stages, with check sizes varying according to the company’s needs. Their strategy involves not just funding but also providing strategic guidance and access to Intel’s extensive network of partners and customers, fostering rapid growth and market entry. The firm has a track record of successful exits, with 35 portfolio companies going public, such as ZEEKR and Astera Labs. Intel Capital also prioritizes diversity, having launched a $125 million fund dedicated to businesses led by women and underrepresented minorities. Intel Capital is led by experienced professionals like Wendell Brooks, who have deep expertise in technology and investment. They encourage startups to approach them through their well-defined programs, offering a blend of financial support and strategic advice to drive innovation and growth in the tech ecosystem.

Intermountain Ventures is the strategic venture capital and innovation arm of Intermountain Health, one of the largest not-for-profit healthcare systems in the western United States, headquartered in Salt Lake City, Utah. Founded in 2012, the firm invests in transformational early- and growth-stage companies aimed at improving healthcare delivery, operations, patient experience, and clinical outcomes. Managing Partner Nickolas Mark leads a team of nine, including three partners, deploying $1 to $5 million per company across Series A, B, and C rounds. Six primary investment focus areas structure the portfolio: Enterprise Enablement, Care Site Optimization, Workforce Transformation, Consumer Experience, Clinical Advancement, and Proactive Care. As of January 2026, Intermountain Ventures has invested in 27 companies with an exceptional exit record. The portfolio includes 2 unicorns in Freenome Health and Olive, and 3 IPOs: Omada Health on NASDAQ in June 2025 at a $1.06 billion market cap and Recursion Pharmaceuticals on NASDAQ at a $2.92 billion market cap. Ten acquisitions have been completed, including Armis, which was acquired by ServiceNow in December 2025 for $7.75 billion — a cybersecurity outlier that represents one of the largest outcomes from a healthcare-focused CVC portfolio. The most recent investment was knownwell at Series B in October 2025, with four total investments made in 2025. Intermountain Ventures provides portfolio companies with clinical expertise, de-identified data access, and integration opportunities within the Intermountain Health system, creating a meaningful channel for real-world validation that pure financial investors cannot match. The firm co-invests with other health system venture arms including Triventures, Health Enterprise Partners, and Ascension Ventures. Intermountain Health has also joined Microsoft, Gates Ventures, Epic, and West Health in an initiative to address healthcare access challenges in rural America.

Interplay is a comprehensive venture capital firm that supports innovative startups through multiple avenues, including venture capital, an incubator, a foundry, and a family office. Founded with the mission to accelerate the journey of entrepreneurs, Interplay invests in early-stage tech companies, particularly those focusing on B2B marketplaces and vertical software. The firm's venture capital arm typically invests $500K to $2M in seed to Series B rounds, with a preference for Series A. They reserve capital for follow-on investments in their top-performing portfolio companies. The incubator program offers a $50K cash investment and a 6-month intensive program in exchange for a 6% equity stake, focusing on pre-seed and seed-stage companies. Interplay's foundry is designed to identify and fill gaps in the market by developing commercially viable solutions, often based on internal ideas. Ascend, the family office, evaluates opportunities at any stage and aims to increase exposure to innovation for entrepreneurs who have already succeeded in the startup ecosystem. Notable achievements include the closing of their $45M Fund III, targeted at B2B marketplaces and vertical software companies, and active involvement in over 40% of Fund III’s capital deployment. The firm also operates multiple service companies and communities to support entrepreneurs and investors.

InterWest Partners, established in 1979, is a venture capital firm focused on early-stage investments in the information technology and healthcare sectors. Based in Menlo Park, California, the firm has raised over $2.8 billion across ten funds. Throughout its history, InterWest has backed more than 250 companies, achieving 97 IPOs and participating in 95 acquisitions. InterWest Partners IX, one of their notable funds, closed at $606 million and primarily invests in early-stage companies within its targeted sectors. The firm is known for its successful investments in companies such as Doximity, Canva, Braze, and Glaukos. InterWest's approach focuses on partnering with world-class entrepreneurs to build leading companies in IT and healthcare, supporting them through various growth stages. While InterWest Partners is not currently seeking new investments, their legacy includes influential early wins in companies like Xilinx and CIENA in the IT sector, and COR Therapeutics and Ventritex in healthcare, cementing their reputation as a key player in the venture capital landscape.

Intudo Ventures, founded in 2017 by Patrick Yip and Eddy Chan, is a pioneering venture capital firm that exclusively invests in Indonesian startups. With a concentrated portfolio approach, Intudo focuses on sectors like agriculture, B2B & enterprise, education, finance, healthcare, and logistics. The firm typically invests between $1 million and $10 million, primarily in early-stage and Series A rounds, but also participates in Series B and C rounds for its established portfolio companies. Intudo has built a reputation for backing high-potential companies such as Pintu, TaniHub, and Gredu. Their strategy leverages the expertise of returnee Indonesians who have gained experience and networks abroad, particularly from the U.S. This approach is bolstered by programs like the Pulkam S.E.A. Turtle Fellowship, which helps integrate returning talent into Indonesia's tech ecosystem. The firm’s deep local involvement allows them to maintain close relationships with their portfolio companies, providing significant support beyond just capital. Intudo ensures every investment is strategically aligned with Indonesia's regulatory environment and market dynamics, giving their companies a competitive edge. Key team members include co-founders Eddy Chan and Patrick Yip, who bring extensive experience in venture capital and entrepreneurial ventures across Silicon Valley and Asia. Intudo Ventures is headquartered in Jakarta, Indonesia, and continues to champion the growth of the local digital economy through its targeted investment strategy and hands-on approach.

Inventages Venture Capital, founded in 2000 by Gunnar Weikert, is the venture capital arm of Nestlé, headquartered in Nassau, Bahamas. The firm specializes in health care, life sciences, pharmaceuticals, cosmeceuticals, enabling technologies, and medical devices. Inventages has a broad investment focus, participating in seed, early, mid, and late-stage ventures. Notable investments include Accera, a biotechnology firm focused on therapies for neurodegenerative diseases, and Phagenesis, which develops treatments for dysphagia. Other significant investments are Shield Therapeutics, known for its iron deficiency treatments, and Cognoptix, which is developing diagnostics for Alzheimer's disease​. Inventages typically invests with an average round size of $14 million, demonstrating a strong commitment to substantial funding rounds. The firm is actively involved in guiding its portfolio companies through strategic growth and development stages. Key team members include Gunnar Weikert (Founder and CEO), Thomas Bayerl, and Wolfgang Reichenberger, all bringing significant expertise in venture capital and life sciences to the table. Inventages is particularly noted for its rigorous due diligence process and a strong focus on the commercial viability of scientific innovations. This approach has enabled them to support groundbreaking developments in health and wellness sectors​.

Inventure is a venture capital firm founded in 2005, headquartered in Helsinki, Finland, with a focus on early-stage investments across the Nordic and Baltic regions. The firm supports innovative startups in sectors ranging from deep tech to consumer internet brands. Inventure’s investment strategy centers around being the first institutional investor in most of its portfolio companies, providing capital and guidance to help them scale. The firm is known for backing over 90 companies, including notable successes like Wolt, Swappie, and Stravito. With ticket sizes ranging from €300,000 to €5 million, Inventure has raised significant capital across multiple funds, the latest announced in 2022. This enables the firm to provide critical early-stage funding to founders tackling unique challenges in their respective regions. Inventure operates as a generalist fund but with strong conviction in the teams it backs, emphasizing the importance of supporting ambitious founders. The firm’s hands-on approach helps startups overcome early-stage hurdles, offering both financial support and strategic resources. Through its offices in Helsinki and Stockholm, Inventure has built a robust network across the Nordic and Baltic startup ecosystem, making it a key player in the region’s venture capital landscape. In addition to its financial investments, Inventure also assists portfolio companies with talent acquisition, product development, and international expansion, ensuring they have the tools necessary for long-term success.

Inveready, founded in 2008 and headquartered in Barcelona, is a prominent asset manager in Spain, specializing in various stages of venture capital, growth capital, venture debt, strategic public equity, private equity, and infrastructure investments. With over €1.2 billion in assets under management and a portfolio of 220 companies, Inveready has a strong track record of supporting innovative and high-growth ventures. The firm’s investment strategies span multiple sectors, including technology, biotech, fintech, medtech, and industrial technologies. Notable portfolio companies include Feedzai, which has achieved unicorn status, and several others that have been acquired by major multinationals such as Intel, Symantec, and Facebook, or have listed on major stock exchanges like Nasdaq and Euronext. Inveready typically invests between €500,000 and €5 million, supporting companies from early stages to growth and beyond. They have offices in San Sebastián, Madrid, and Barcelona, positioning them well to leverage opportunities across Europe and North America. Their unique approach combines traditional equity investments with innovative financing solutions like venture debt and tax lease structures, tailored to minimize dilution for founders while maximizing growth potential.

Invesco Private Capital, a division of Invesco, specializes in a broad range of investments, including early-stage ventures, growth capital, buyouts, and private equity. With over 25 years of experience, they leverage a deep network of industry relationships and extensive market insights to identify and support high-potential startups and emerging private equity managers​. Invesco’s notable investments span across various sectors, including technology, healthcare, and financial services. They have been involved in significant ventures and direct investments that align with their strategy of partnering with innovative and scalable companies. Their comprehensive approach includes not only capital investment but also strategic support and operational expertise to help portfolio companies achieve sustainable growth. For more information on their investment strategies and portfolio, you can visit the Invesco website or explore their detailed profiles on investment platforms like PitchBook and Crunchbase.

Invest Nebraska is a venture capital firm based in Lincoln, Nebraska, dedicated to supporting early-stage startups across various industries. As a nonprofit fund, it focuses on driving economic growth within Nebraska by investing in technology-driven companies that demonstrate a potential for scalability and local impact. Invest Nebraska has made significant strides in sectors like AgTech, life sciences, IoT, cloud services, and proprietary food technology, among others. Their portfolio reflects a commitment to fostering innovation in areas including healthcare, financial technology, and agriculture. The firm partners closely with state initiatives, including the Business Innovation Act, which provides capital for promising startups to scale within Nebraska. An average initial check size of $250k is typical, aimed at providing 12-18 months of runway. Recent collaborations, such as the Burlington Capital Ag-Venture Fund, show their strategic focus on strengthening AgTech innovation across the Midwest, bringing together local expertise and a global perspective to support agricultural startups. The leadership team, including CEO Dan Hoffman and Principal Ben Williamson, brings deep local expertise, facilitating connections between startups and a broader network of investors. Invest Nebraska values companies with a solid plan for in-state growth and a robust understanding of their market, making it a key player in developing Nebraska's entrepreneurial ecosystem. Entrepreneurs seeking investment are encouraged to demonstrate clear product-market fit, recurring revenue, and a commitment to leveraging Nebraska's unique economic landscape.

Invest-NL is a Dutch impact investment firm dedicated to financing innovative projects and companies that drive sustainability and innovation in the Netherlands. The firm, established in 2020, focuses on supporting entrepreneurs with substantial plans for a sustainable future. Their mission is to enable projects that may otherwise seem unfinanceable, contributing to major societal transitions such as the shift to a carbon-neutral and circular economy. Invest-NL's investment activities span various sectors, including deep tech, life sciences, energy transition, and agrifood. Notable initiatives include the Dutch Future Fund, which mobilizes up to €1.5 billion for innovative SMEs, focusing on energy transition and sustainability. One of Invest-NL's significant investments is in Regeneration.VC Fund II, a venture capital fund aimed at consumer climate tech. This €5 million investment helps bridge Dutch startups with the U.S. market, providing them with access to American multinationals and capital markets. Invest-NL collaborates with the European Investment Fund (EIF) and the Dutch Ministry of Economic Affairs and Climate to support high-potential ventures, making impactful contributions to both the Dutch economy and global sustainability efforts.

Investec, an Anglo-South African international banking and wealth management group, is recognized for its diverse investments and notable projects. The company operates globally, offering financial products and services to clients in Europe, Southern Africa, and the Asia-Pacific region. It is dual-listed on the London and Johannesburg Stock Exchanges. One of Investec's significant projects is its partnership with Proparco on the Transforming Financial Systems for Climate (TFSC) program. This initiative supports South Africa's transition to a low-carbon economy with an $80 million climate finance-dedicated credit facility aimed at expanding climate-related financing in the region. This project aligns with South Africa's goal to reduce carbon emissions by 42% by 2025 and diversify its electricity production away from coal by 2050. Investec has also been instrumental in financing renewable energy projects, such as the €72.5 million facility for WElink's 220MW Solara4 solar PV farm in Portugal, Europe's largest unsubsidized solar project. This project will provide sustainable energy to 200,000 homes and reduce carbon emissions significantly. Moreover, Investec's energy and infrastructure finance division has arranged over $11 billion in financing in North America over the past three years, demonstrating its expertise in conventional and renewable power, midstream oil and gas, transportation, and digital infrastructure. These initiatives highlight Investec's commitment to sustainability and its strategic focus on supporting large-scale renewable projects and climate-related investments globally.

Investible is a prominent early-stage venture capital firm based in Sydney and Singapore, focusing on investments in Australia, New Zealand, Southeast Asia, and globally. Established to support visionary founders, Investible targets pre-seed to Series A companies across various sectors, including fintech, martech, edtech, healthtech, and climate tech. The firm operates through several funds, including the $51.6 million Early-Stage Fund 2 and the Climate Tech Fund. They also have a unique investment syndicate called Club Investible, which includes over 150 members who invest alongside the firm's funds. This model allows Investible to offer comprehensive support, including capital, expertise, and an extensive network of advisors and industry connections. Investible's portfolio includes notable companies like Quantum Brilliance and Manetta's Seafood Market, highlighting their diverse investment strategy. They emphasize a founder-friendly approach, aiming to provide ongoing support as businesses grow, with check sizes typically ranging from AU$250,000 to AU$1.5 million.

Investo Capital is an early-stage venture capital firm based in Aalborg, Denmark, with a strong focus on investing in Danish technology-driven companies. Established in 2018, Investo Capital targets early-growth tech companies that demonstrate strong strategic potential and scalability, particularly in sectors such as SaaS, med-tech, cleantech, and Industry 4.0. The firm typically invests between €2 million and €5 million, with the potential to increase this up to €10 million through co-investments with other partners. Backed by cornerstone investors like HEARTLAND A/S and NOVI Innovation A/S, Investo Capital leverages its team's extensive experience in Nordic venture and private equity. The team, which includes seasoned professionals such as Henrik Lundum and Jesper Jespersen, has a long track record in successfully guiding startups from seed stage to significant market impact. Their approach is hands-on, with Investo Capital often taking an active role in the companies they back, including board representation and strategic guidance. Investo's investment strategy is comprehensive, beginning with an in-depth screening process to evaluate the company’s commercial potential and growth strategy. They focus on companies that not only have a solid business model but also offer unique technological solutions. The firm’s portfolio includes notable investments in companies like TracInnovations, Brainreader, and Tentoma, all of which are at the forefront of innovation in their respective fields​.

IP Group is a leading FTSE-250 listed venture capital firm specializing in intellectual property commercialization. Notable for its deeptech focus, IP Group has been instrumental in developing over 300 companies, with significant investments in life sciences, cleantech, and cutting-edge technologies. High-profile portfolio companies include Oxford Nanopore Technologies, Centessa Pharmaceuticals, and Hinge Health. Geographically, IP Group maintains a strong presence in the UK, with partnerships across 17 UK universities and significant ties to institutions in the US, Australia, and New Zealand. The firm’s investment strategy emphasizes patient capital and long-term support, particularly in university spin-outs. IP Group invests at various stages, from seed to growth, and often continues funding as companies scale. This approach includes providing commercialization assistance, executive recruitment, and securing growth-stage capital from co-investors. The firm’s evergreen structure allows it to sustain the lengthy development cycles typical of deeptech ventures. Key team members include CEO Greg Smith and COO Alan Aubrey, who bring extensive expertise in technology transfer and IP management. IP Group typically leads investment rounds and prefers to be approached by startups with strong IP and technological differentiation. With an average check size of over £1.5m for VC rounds, the firm remains highly active, having invested £1bn in the first half of the current financial year. In summary, IP Group’s robust support system, extensive university partnerships, and strategic patience make it a cornerstone for deeptech and innovative startups looking to transform breakthrough ideas into commercial realities.

IQ Capital is a leading venture capital firm based in Cambridge, UK, specializing in deep tech investments. With over $1 billion in assets under management, IQ Capital targets seed to Series A stage startups across the UK and Europe, focusing on transformative technologies like AI, quantum computing, robotics, and synthetic biology. Notable investments include Grapeshot (acquired by Oracle), Bloomsbury AI (acquired by Facebook), and Thought Machine, a prominent cloud banking startup valued at $2.7 billion. IQ Capital's strategy emphasizes investing in IP-rich technologies with global market potential. Initial investments range from $2.5 million to $5 million, with follow-on investments reaching up to $15 million. The firm recently closed its fourth venture fund at $200 million to support deep tech companies from seed through growth stages. Key team members include co-founders Max Bautin and Kerry Baldwin, both with extensive experience in deep tech venture capital. The team has grown significantly, adding experts like Rick Hao and Daniel Carew, who bring diverse expertise across AI, cybersecurity, and advanced manufacturing.

IRIS Ventures is a growth equity firm focused on supporting visionary founders building consumer brands that prioritize health, wellness, and convenience. Launched in 2021, IRIS operates across Europe, the UK, and the US, investing in tech-enabled solutions that aim to make life healthier and more sustainable. The firm champions companies that embrace responsible innovation, transparency, and diversity, with a particular emphasis on long-term societal impact. Key brands in the IRIS Ventures portfolio include Saysh, the women’s athletic footwear company founded by Olympic athlete Allyson Felix; Artemest, a luxury marketplace that showcases Italian craftsmanship; and Vicio, a rapidly growing food delivery startup in Spain. Other investments, like Biomel, which offers plant-based gut health products, and Olistic, a wellness brand focused on hair care, reflect IRIS’s commitment to well-being and modern consumer needs. The firm’s investment approach is centered around empowering brands that resonate with today's consumers, helping them scale while fostering positive change. IRIS Ventures seeks out companies at the intersection of health, sustainability, and convenience, focusing on those that can drive both economic returns and social impact. Their mission is to back founders who are rewriting the future of consumer goods, with a strong belief that brands should not only deliver exceptional products but also contribute to a more inclusive and healthier world​.

IrishAngels is an angel investing network associated with the University of Notre Dame, focusing on pre-seed and seed stage startups. With a network of over 250 investors, IrishAngels has deployed more than $20 million in capital across various sectors including B2B, consumer, and medical companies. They provide substantial support through their active network, ensuring that companies receive not only financial backing but also strategic guidance and resources for growth. Notable investments in their portfolio include Elevate K-12, a platform providing live streaming online instruction; Genomenon, which offers a comprehensive source of genomic evidence; and Hallow, a Christian prayer app that provides guided religious content. They also have investments in technology-driven companies like Groupsense, which tracks cyber threats, and Fulcrum, which powers a connected manufacturing supply chain through machine learning. IrishAngels holds quarterly meetings, currently conducted remotely, providing investors with opportunities for networking and business development. The group emphasizes a collaborative and founder-friendly approach, maintaining regular check-ins to support portfolio companies.

Iron Wolf Capital is an early-stage venture capital firm based in Vilnius, Lithuania, and London, specializing in funding startups that focus on disruptive technologies with global potential. With a particular focus on deep tech, AI, SaaS, and IoT, Iron Wolf Capital invests in pre-seed to early growth companies. The firm typically invests between €250,000 and €2 million, helping to scale businesses that demonstrate innovative products, technology, or business models. Their portfolio spans diverse sectors, including companies like Millo, a smart blender startup; Litilit, a developer of high-end fiber lasers; and Rendin, a platform revolutionizing the home rental process. Iron Wolf Capital supports these companies not only financially but also by leveraging its team's deep entrepreneurial and financial experience, guiding startups through the complex stages of growth. Iron Wolf Capital’s roots in the Baltics, combined with a global outlook, enable them to focus on building bridges between local talent and international markets. The firm is known for its hands-on approach, providing strategic advice and access to a robust network of partners and experts to foster success. The firm also emphasizes ESG (Environmental, Social, Governance) principles, integrating sustainability into its investment strategies to ensure long-term value creation.

iSeed Ventures, based in San Francisco, California, is an early-stage venture capital firm focused on digital health, consumer mobile technology, and IoT. Founded by Adam Lin and Bryan Cheng, the firm invests in seed to early-stage startups, providing not only capital but also strategic guidance and support to foster growth and innovation. iSeed Ventures has a diverse portfolio of notable investments. These include 9amHealth, a virtual diabetes care clinic; Anyline, a mobile data capture and AI company; and BloomSky, which provides innovative weather IoT solutions. They have also supported Canvas Medical, a software platform for healthcare delivery, and Care Innovations, a healthcare management services provider acquired by PRA Health Sciences. The firm has successfully exited several investments, including 1DocWay, an online platform for virtual care acquired by United Healthcare, and mySugr, which was acquired by Roche. iSeed Ventures aims to leverage their extensive network and expertise to help early-stage companies achieve significant milestones and exits. With a total of 44 investments and 5 successful exits, iSeed Ventures continues to focus on high-growth potential startups in the US and globally, emphasizing their commitment to transforming healthcare and consumer technology industries.

iSeed Ventures, founded in 2014, is a venture capital firm based in San Francisco, California, that focuses on seed-stage investments in sectors such as digital health, the Internet of Things (IoT), and consumer technology. The firm aims to support innovative startups with high growth potential and has a diverse portfolio of companies across various industries. Some of the notable investments by iSeed Ventures include 9am.health, a virtual diabetes clinic that secured $3.7 million in seed funding to provide better diabetes care in the U.S., and CoderSchool, an online coding education platform based in Vietnam, which raised $2.6 million in pre-Series A funding to expand its reach. Other significant investments include Jeff, a fintech company focused on lending, and AvalonMeta Ventures, which combines education and gaming. iSeed Ventures is known for its commitment to supporting early-stage startups through strategic investments and active mentorship. The firm typically makes investments with an average round size of $2 million and has been involved in various rounds annually, showcasing its active role in the venture capital ecosystem.

iSelect Fund is a St. Louis-based venture capital firm focusing on early-stage investments in sectors that have a profound global impact, such as agriculture, food, and healthcare. They invest in companies addressing critical challenges like sustainable food production, improved healthcare delivery, and innovations that enhance human health through better nutrition. iSelect’s portfolio includes over 60 companies, such as Harpe Bioherbicide and Kula Bio, which are tackling sustainability in agriculture through natural and biotechnological solutions. The firm operates with an evergreen fund structure, offering ongoing investment opportunities with low minimums, making venture capital more accessible to accredited investors. Their investment strategy revolves around a balanced, diversified portfolio approach, which allows them to spread risk while supporting transformative companies. iSelect focuses on startups that leverage data, technology, and science to drive innovation, particularly in the areas of food systems, agtech, and health tech. Their emphasis on impact investing means they are highly selective, looking for businesses with the potential for significant financial returns as well as positive societal outcomes. They typically avoid sectors like cannabis and direct-to-consumer models, and focus on companies that can create long-term, scalable change.

iSGS Investment Works, founded in 2014 and headquartered in Tokyo, Japan, is a venture capital firm that focuses on early to late-stage investments. They have a diverse portfolio, with 63 investments to date, primarily in technology-driven sectors such as artificial intelligence, fintech, and consumer products. Notable investments include companies like Startbahn, which focuses on blockchain technology for the art industry, and SOUNDRAW, an AI-driven music creation platform. They have had significant exits, such as ExaWizards and Unipos, highlighting their success in fostering growth in innovative companies. The firm is led by key figures including Makiko Sato, founder and representative partner, Kazuhito Goshima, CEO, and Kei Sugawara, CFO. Their team combines extensive experience in technology and finance to support their portfolio companies effectively.

Isomer Capital is a London-based venture capital firm that operates as a "fund of funds," primarily investing in early-stage European tech VCs. Founded by Joe Schorge, Isomer has built a reputation for backing some of Europe's leading venture firms like Seedcamp, Hoxton Ventures, and Entrepreneur First, giving it exposure to high-potential startups across various sectors. With over 70 VC firms and 29 unicorns in its portfolio, Isomer Capital focuses on identifying promising early-stage ventures across Europe. Notable investments include companies like UiPath, Deliveroo, and Wefox. Their strategy includes direct co-investments in top-performing startups when they are ready to scale, secondary investments, and a strong commitment to providing liquidity solutions to founders and early investors. Their latest fund, Isomer Capital III, targets €250 million, continuing their focus on European growth-stage startups. They plan to deploy this fund over the next few years, with key supporters such as British Business Investments and the European Commission.

Israel HealthCare Ventures (IHCV) is a leading Israeli life sciences venture capital fund founded in 2000 and based in Tel Aviv. The firm has raised two funds, IHCV I and IHCV II, cumulatively investing approximately $135 million across 27 companies in Israel-based startups. Founder and Managing Partner Hadar Ron leads the firm with a hands-on investment approach, preferring to hold board seats in portfolio companies and providing professional advice, ongoing management support, and access to a global network of medical and financial contacts. IHCV invests from seed to later stages across medical devices, biotechnology, pharmaceuticals, life sciences, nanotechnology, and medical-related IT. Approximately 75% of the portfolio consists of medical device companies, with the remaining 25% in pharmaceuticals and biotechnology. Investment checks are typically in the $3 million to $10 million range, and the firm leads rounds. The portfolio spans medical fields including cardiology, orthopedics, oncology, general surgery, gastroenterology, esthetics, and central nervous system disorders, covering therapeutic and diagnostic technologies as well as rehabilitation, drug delivery, and consumer healthcare. Co-investors include Teva Pharmaceuticals. The portfolio has achieved 3 IPOs and 3 acquisitions. The most significant exit is Mazor Robotics, a surgical robotics company acquired by Medtronic for $1.7 billion in September 2018. Gamida Cell, a cell therapy company, completed its NASDAQ IPO in October 2018, raising $139 million in total. Xylo Technologies also achieved an IPO exit. Other notable companies in the portfolio include CorAssist, OrSense, and Optonol. IHCV's two-decade track record in Israeli life sciences reflects the firm's consistent focus on technology that addresses large patient populations with unmet clinical needs. The firm's extensive global medical network enables portfolio companies to access regulatory expertise, clinical partnerships, and commercial relationships across the United States, Europe, and Asia.

Israel Secondary Fund (ISF) is a pioneering secondary investment firm established in 2008, focusing on providing liquidity solutions within Israel's high-tech ecosystem. Headquartered in Herzliya, ISF has built a robust presence in the secondary market by facilitating over 80 transactions, offering stakeholders opportunities to sell their interests in tech companies and venture funds. The firm manages over $500 million, catering to needs ranging from direct secondary purchases of shares from founders and employees to acquiring LP positions in VC and private equity funds. ISF’s strategy centers on its "Triple Win Approach," ensuring mutual benefits for sellers, ISF, and the companies involved. They conduct transactions typically starting from $1 million, becoming long-term partners to their portfolio companies, which include notable names like MyHeritage, Aidoc, and Verbit. This involvement often extends to participating in future funding rounds and structured deals that provide liquidity while preserving the growth potential of the assets. The firm is led by experienced partners, including co-founders Dror Glass and Shmuel Shilo, who leverage decades of expertise in investment and finance. ISF recently raised $312 million for its third fund, highlighting its critical role in enabling liquidity in a market where startups might face long pathways to exits, especially amid IPO delays. By offering these tailored liquidity solutions, ISF continues to support the sustained growth of Israel’s tech sector.

IST Cube is a venture capital fund based in Austria, focusing on science-based startups and academic spin-offs that are pioneering innovative solutions in deep tech and other high-impact sectors. Founded in partnership with the Institute of Science and Technology Austria (IST Austria), IST Cube is designed to help early-stage companies commercialize breakthrough technologies derived from academic research. The fund primarily targets investments in deep tech sectors such as IT, healthcare, energy, and advanced materials. With a typical investment range between €1 million and €2 million, IST Cube supports startups from pre-seed to later stages, with a strong focus on long-term development and growth. The firm is committed to backing companies that combine cutting-edge science with scalable business models. IST Cube provides its portfolio companies with more than just capital. The fund also offers strategic guidance, mentorship, and access to a broad network of industry experts and collaborators. Startups benefit from IST Cube's deep understanding of intellectual property, business development, and technology transfer, which helps founders navigate the complexities of scaling science-driven innovations. Some of IST Cube's notable investments include Prewave, an AI-driven supply chain monitoring platform, and contextflow, a company specializing in AI-powered medical imaging solutions. By bridging the gap between academic innovation and market application, IST Cube is fostering the next generation of groundbreaking technologies.

IT-Farm is a venture capital firm that focuses on early-stage technology startups with transformative potential. Founded in 1999, IT-Farm is based in Tokyo, Japan, and has expanded its reach to include investments in North America and Asia. The firm has a strong track record of supporting innovative companies in sectors such as IT, AI, IoT, and cleantech. Some notable startups in IT-Farm's portfolio include Plus One Robotics, which offers industrial robotics solutions for material handling in e-commerce, and TerraClear, an ag-tech company specializing in automated rock-picking solutions for agriculture. These investments highlight IT-Farm's commitment to backing companies that address significant industry challenges through advanced technology​. IT-Farm's investment strategy emphasizes hands-on support and strategic guidance, helping startups navigate early-stage development and scale their operations. The firm provides critical resources beyond capital, such as mentorship and connections to a global network of industry experts and potential partners. The team at IT-Farm includes experienced investors and industry veterans who bring a wealth of knowledge and expertise to their portfolio companies. This collaborative approach has been instrumental in fostering innovation and driving growth across various technology sectors.

IT-Translation is a Paris-based venture capital firm founded in 2011, specializing in early-stage investments in digital technology startups that emerge from public and private research. The firm plays a unique dual role as both an investor and co-founder, providing not just financial backing but also operational support to help transform innovative research into marketable products and services. IT-Translation typically invests up to €300,000 in the earliest stages of a startup, often co-founding the company alongside researchers. This approach is deeply collaborative, with IT-Translation taking a hands-on role in guiding startups through product development, market entry, and scaling. The firm holds an initial 15% equity stake, which can increase up to 30% through subsequent investment rounds. Their model is particularly focused on leveraging the technological potential of French research to create high-value companies capable of leading in the digital space. The firm’s investments are rooted in their commitment to fostering innovation and supporting the growth of the French tech ecosystem. Their portfolio spans a diverse range of sectors within digital technology, from AI to cybersecurity, demonstrating their broad impact across the industry. By aligning their financial investments with strategic support, IT-Translation has established itself as a key player in the early-stage deep tech ecosystem in France.

Iter Investments is a venture capital firm headquartered in Fort Lauderdale, Florida, focusing on early-stage companies within the psychedelic industry. Established in 2021 by Dustin Robinson and Robert Velarde, the firm aims to transform the mental and behavioral health sector by supporting innovative companies leveraging psychedelics for therapeutic purposes. Iter Investments raised over $20 million for its inaugural fund, which it uses to back ventures across the psychedelic value chain, from drug development and clinics to technology and digital therapeutics. The firm’s portfolio includes companies like Psilera, Beckley Psytech, and Awakn Life Sciences, which work on developing treatments for conditions such as depression, PTSD, and addiction. Iter also invests in supporting infrastructure, such as Psygen, a supplier of psychedelic ingredients, and Tripp, which integrates virtual reality with psychedelic science for therapeutic applications. Furthermore, they have established Nucleus, a holding company for media and data assets, to help expand their reach across the industry ecosystem. The team at Iter consists of experts across law, science, and healthcare, ensuring robust due diligence and strategic support for their portfolio companies. By leading funding rounds and taking board seats, Iter Investments provides not only capital but also guidance to navigate the complex regulatory and commercial landscape. Their holistic approach aims to bridge the gap between groundbreaking research and widespread commercialization, ensuring that advancements in psychedelic therapies can effectively reach the market.

ITIC (Industrial Technology Investment Corporation) is a venture capital arm of Taiwan's Industrial Technology Research Institute (ITRI), founded in 1979. Over the years, ITIC has invested more than $400 million across a wide range of sectors, including semiconductors, biotech, precision machinery, and automotive technologies. The firm focuses on both early and growth-stage investments, leveraging the vast technical expertise and resources of ITRI, which includes over 6,000 researchers and 25,000 patents. What sets ITIC apart is its deep involvement in R&D and the global ecosystem of partnerships it has built over four decades, connecting startups with manufacturers, market intelligence, and corporate partners. Some of its notable portfolio companies include UMC and AUO. ITIC also manages various funds, such as the Golden Asia Fund and the Digital Economy Fund, targeting emerging tech trends like AI, IoT, and advanced materials. ITIC’s CVC (Corporate Venture Capital) program helps established companies invest in startups that align with their strategic goals, reducing risks through expert guidance and post-investment support.

ITOCHU Technology Ventures (ITV) is the corporate venture capital arm of ITOCHU Corporation, one of Japan's largest trading companies. Established in July 2000 and headquartered in Minato-ku, Tokyo, ITV leverages ITOCHU's extensive global network, including Silicon Valley connections dating back to the 1980s. The firm is led by President and CEO Suguru Yamaryo with a team of 12 employees and eight partners. ITV's most recent fund, Technology Ventures VI, completed its fundraise in March 2025 as the firm's largest at 16.1 billion yen (approximately $107 million), with ITOCHU itself investing 2.5 billion yen. Cumulative investments across Funds I through V total more than 39 billion yen (approximately $260 million) across 180 portfolio companies and 210 total investment transactions. ITV invests primarily in early-stage startups across Japan and the United States, with typical checks around $1 million to $3 million at seed, Series A, and Series B stages. Investment focus areas include software, AI, SaaS, e-commerce, health technology, and cleantech. The portfolio has achieved 37 exits including 7 IPOs and multiple acquisitions. Listed portfolio companies include Mercari, the C2C marketplace trading on the Tokyo Stock Exchange; Raksul, a printing marketplace also on the Tokyo Stock Exchange; VRAIN Solution, an industrial AI company listed on the TSE; and SentinelOne, the cybersecurity company that IPO'd on NYSE. Recent investments include Sakana AI (open-source AI), Teamshares (employee buyout platform in the US), and Thinker, invested in August 2025. LP investors in TV6 include MUFG Bank, SMBC Nikko Securities, Resona Bank, and Tokyo Century Corporation. ITV's vision of enabling society to evolve by creating new industries reflects a mandate that extends beyond corporate synergy to genuine financial returns and ecosystem impact. The fund's six-fund track record across more than two decades positions it as one of the most tenured technology CVCs in the Asia-Pacific region.

IU Ventures is a 501(c)(3) affiliate of Indiana University focused on investing in and supporting early-stage, IU-affiliated startup companies, generating social and economic impact for the university, Indiana, and beyond. Founded in 1997 and based in Bloomington, Indiana, the organization is led by Tony Armstrong, President and CEO since 2008, and Jason Whitney, Chief Venture Officer and Executive Director, with a team of 28 members including 12 partners. IU Ventures manages three investment programs: the IU Angel Network, the $11 million IU Philanthropic Venture Fund established in 2018 as an evergreen fund, and the Innovate Indiana Fund established in 2010 and now fully invested. The firm leads rounds across pre-seed and seed stages, with checks from $100,000 to $1 million. The portfolio includes 68 companies across life sciences, health technology, enterprise software, fintech, and consumer sectors. IU Ventures focuses on Indiana University's traditional strengths in life and health sciences alongside emerging areas including engineering, cybersecurity, quantum computing, and big data analytics. The portfolio has achieved 1 IPO and 14 acquisitions. MBX Biosciences listed on NASDAQ in September 2024 at a $510 million market cap, the most notable exit. Other acquisitions include Sharpen, PrecisionHawk, Doxly, Encamp, Mentor Collective, Canopy, Probari, Diagnotes, and Qumulex. IU PhV portfolio companies include Confluence Pharmaceuticals, Nerx BioSciences, Scioto Biosciences, NuCurrent, Amplified Sciences, Boardable, MetaCX, and Monument Biosciences. The firm led a $1.9 million seed round of Adipo Therapeutics alongside VisionTech Partners and Elevate Ventures. The most recent investment was in Membershine in December 2025. IU Ventures has received the Mira Award for Investor of the Year for its commitment to investing in diverse founding teams. The organization's university affiliation gives it a direct pipeline to faculty-led spinouts, graduate student ventures, and commercialized research, creating a deal flow channel unavailable to conventional institutional funds.

Institutional Venture Partners (IVP) is one of the original venture capital firms on Sand Hill Road, founded in 1980 in Menlo Park, California, with a five-decade track record of investing in companies that define their industries. The firm manages approximately $7 billion in committed capital across 18 funds, including Fund XVI at $1.5 billion in 2017, Fund XVII at $1.8 billion in 2021, and Fund XVIII at $1.6 billion in 2024. Managing Director Todd Chaffee and General Partners Jules Maltz, Eric Liaw, Somesh Dash, and Tom Loverro lead the firm. Maltz joined in 2008 focusing on internet and software; Loverro joined in 2015 covering consumer and enterprise growth. IVP leads rounds almost exclusively at the Series B stage, backing just a dozen companies each year with checks of $10 to $50 million, typically targeting companies with valuations above $100 million. As of March 2026, the firm has invested in 248 companies with 42 unicorns, more than 130 IPOs, and 104 acquisitions. The portfolio includes Slack, CrowdStrike, Coinbase, Datadog, Discord, Snap, Twitter, Amplitude, and Perplexity. Klarna completed its NYSE IPO in September 2025 at a $15.1 billion market cap. Recent investments include LangChain in October 2025, Whoop, Abridge, Chainguard, and Cape, with 12 new investments in the past 12 months. IVP's investment thesis centers on identifying companies at critical inflection points before the broader market recognizes their trajectory, then providing deep engagement through strategic guidance, network access, and operational expertise to help founders scale from millions to hundreds of millions in revenue. The firm's deliberate focus on a small annual deal count ensures each portfolio company receives sustained attention from the partnership throughout the growth stage.